BioSpace News Archive

These changes realign the current sales, marketing, research and development, and customer service teams in addition to establishing new distribution channel management and medical education teams.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the addition of three new members to its Board of Directors and the retirement of Board member James Quella after nine years of valued service.

The FDA has denied PTC Therapeutics appeal of the Complete Response Letter in relation to the New Drug Application (NDA) for ataluren.

The Gastroenterology Group, PC, a gastroenterology practice based in Reston, Va., announces its expansion into clinical research by partnering with Elligo Health Research.

Scientists at Cedars-Sinai and Emulate, Inc. are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient’s genetic makeup and disease variant—a new approach to precision medicine for improving patient care and health.

Cullinan Oncology, LLC and MAB Discovery GmbH (MABD), announced today the initiation of a collaboration to develop novel antibody therapeutics based on MABD’s unique discovery platform.

MiMedx Group, Inc. announced it will postpone the release of its financial results, as well as the filing of its Form 10-K, for the year ended December 31, 2017.

Baxter International Inc. (NYSE:BAX) today announced a quarterly cash dividend and an expanded authorization for its share repurchase program.

PharmaJet®, the maker of innovative, needle-free injection technology, today announced a global license agreement with Genexine.